Literature DB >> 32408345

Neurofilaments: neurobiological foundations for biomarker applications.

Arie R Gafson1, Nicolas R Barthélemy2, Pascale Bomont3, Roxana O Carare4, Heather D Durham5, Jean-Pierre Julien6,7, Jens Kuhle8, David Leppert8, Ralph A Nixon9,10,11,12, Roy O Weller4, Henrik Zetterberg13,14,15,16, Paul M Matthews1,17.   

Abstract

Interest in neurofilaments has risen sharply in recent years with recognition of their potential as biomarkers of brain injury or neurodegeneration in CSF and blood. This is in the context of a growing appreciation for the complexity of the neurobiology of neurofilaments, new recognition of specialized roles for neurofilaments in synapses and a developing understanding of mechanisms responsible for their turnover. Here we will review the neurobiology of neurofilament proteins, describing current understanding of their structure and function, including recently discovered evidence for their roles in synapses. We will explore emerging understanding of the mechanisms of neurofilament degradation and clearance and review new methods for future elucidation of the kinetics of their turnover in humans. Primary roles of neurofilaments in the pathogenesis of human diseases will be described. With this background, we then will review critically evidence supporting use of neurofilament concentration measures as biomarkers of neuronal injury or degeneration. Finally, we will reflect on major challenges for studies of the neurobiology of intermediate filaments with specific attention to identifying what needs to be learned for more precise use and confident interpretation of neurofilament measures as biomarkers of neurodegeneration.
© The Author(s) (2020). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  biomarkers; neurodegeneration; neurofilaments; neuroinflammation; traumatic brain injury

Mesh:

Substances:

Year:  2020        PMID: 32408345      PMCID: PMC7363489          DOI: 10.1093/brain/awaa098

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  233 in total

1.  A novel NF-L mutation Pro22Ser is associated with CMT2 in a large Slovenian family.

Authors:  Donna-Maria Georgiou; Janez Zidar; Marko Korosec; Lefkos T Middleton; Theodoros Kyriakides; Kyproula Christodoulou
Journal:  Neurogenetics       Date:  2002-10       Impact factor: 2.660

2.  Cerebrospinal Fluid Clearance in Alzheimer Disease Measured with Dynamic PET.

Authors:  Mony J de Leon; Yi Li; Nobuyuki Okamura; Wai H Tsui; Les A Saint-Louis; Lidia Glodzik; Ricardo S Osorio; Juan Fortea; Tracy Butler; Elizabeth Pirraglia; Silvia Fossati; Hee-Jin Kim; Roxana O Carare; Maiken Nedergaard; Helene Benveniste; Henry Rusinek
Journal:  J Nucl Med       Date:  2017-03-16       Impact factor: 10.057

3.  Phenotypic analysis of neurofilament light gene mutations linked to Charcot-Marie-Tooth disease in cell culture models.

Authors:  Raul Perez-Olle; Sidonie T Jones; Ronald K H Liem
Journal:  Hum Mol Genet       Date:  2004-07-28       Impact factor: 6.150

Review 4.  Huntington's disease: revisiting the aggregation hypothesis in polyglutamine neurodegenerative diseases.

Authors:  Ray Truant; Randy Singh Atwal; Carly Desmond; Lise Munsie; Thu Tran
Journal:  FEBS J       Date:  2008-07-15       Impact factor: 5.542

5.  The Role of Calpain and Proteasomes in the Degradation of Carbonylated Neuronal Cytoskeletal Proteins in Acute Experimental Autoimmune Encephalomyelitis.

Authors:  Suzanne M Smerjac; Jianzheng Zheng; Che-Lin Hu; Oscar A Bizzozero
Journal:  Neurochem Res       Date:  2018-09-24       Impact factor: 3.996

6.  Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's disease.

Authors:  Oliver Preische; Stephanie A Schultz; Anja Apel; Jens Kuhle; Stephan A Kaeser; Christian Barro; Susanne Gräber; Elke Kuder-Buletta; Christian LaFougere; Christoph Laske; Jonathan Vöglein; Johannes Levin; Colin L Masters; Ralph Martins; Peter R Schofield; Martin N Rossor; Neill R Graff-Radford; Stephen Salloway; Bernardino Ghetti; John M Ringman; James M Noble; Jasmeer Chhatwal; Alison M Goate; Tammie L S Benzinger; John C Morris; Randall J Bateman; Guoqiao Wang; Anne M Fagan; Eric M McDade; Brian A Gordon; Mathias Jucker
Journal:  Nat Med       Date:  2019-01-21       Impact factor: 53.440

7.  Reorganization of multivesicular bodies regulates MHC class II antigen presentation by dendritic cells.

Authors:  M Kleijmeer; G Ramm; D Schuurhuis; J Griffith; M Rescigno; P Ricciardi-Castagnoli; A Y Rudensky; F Ossendorp; C J Melief; W Stoorvogel; H J Geuze
Journal:  J Cell Biol       Date:  2001-10-01       Impact factor: 10.539

8.  Deregulation of PKN1 activity disrupts neurofilament organisation and axonal transport.

Authors:  Catherine Manser; Alison Stevenson; Steven Banner; Jennifer Davies; Elizabeth L Tudor; Yoshitaka Ono; P Nigel Leigh; Declan M McLoughlin; Christopher E Shaw; Christopher C J Miller
Journal:  FEBS Lett       Date:  2008-06-02       Impact factor: 4.124

9.  Convective influx/glymphatic system: tracers injected into the CSF enter and leave the brain along separate periarterial basement membrane pathways.

Authors:  Nazira J Albargothy; David A Johnston; Matthew MacGregor-Sharp; Roy O Weller; Ajay Verma; Cheryl A Hawkes; Roxana O Carare
Journal:  Acta Neuropathol       Date:  2018-05-12       Impact factor: 17.088

10.  Pathological Proteins Are Transported by Extracellular Vesicles of Sporadic Amyotrophic Lateral Sclerosis Patients.

Authors:  Daisy Sproviero; Sabrina La Salvia; Marta Giannini; Valeria Crippa; Stella Gagliardi; Stefano Bernuzzi; Luca Diamanti; Mauro Ceroni; Orietta Pansarasa; Angelo Poletti; Cristina Cereda
Journal:  Front Neurosci       Date:  2018-07-19       Impact factor: 4.677

View more
  43 in total

1.  Neurofilament light plasma concentration positively associates with age and negatively associates with weight and height in the dog.

Authors:  Jackie Perino; Margaret Patterson; Mehdi Momen; Mina Borisova; Amanda Heslegrave; Henrik Zetterberg; Jordan Gruel; Emily Binversie; Lauren Baker; John Svaren; Susannah J Sample
Journal:  Neurosci Lett       Date:  2020-12-24       Impact factor: 3.046

2.  Plasma neurofilament light chain: A biomarker predicting severity in patients with acute ischemic stroke.

Authors:  Jixia Wu; Daqing Wu; Youbao Liang; Zhen Zhang; Lei Zhuang; Zhaoping Wang
Journal:  Medicine (Baltimore)       Date:  2022-07-01       Impact factor: 1.817

3.  Selenium nanoparticles derived from Proteus mirabilis YC801 alleviate oxidative stress and inflammatory response to promote nerve repair in rats with spinal cord injury.

Authors:  Xiangyu Liu; Yingji Mao; Shengwei Huang; Weifeng Li; Wei Zhang; Jingzhou An; Yongchao Jin; Jianzhong Guan; Lifang Wu; Pinghui Zhou
Journal:  Regen Biomater       Date:  2022-06-23

4.  Serum neurofilament light chain levels in Covid-19 patients without major neurological manifestations.

Authors:  Federico Verde; Ilaria Milone; Ilaria Bulgarelli; Silvia Peverelli; Claudia Colombrita; Alessio Maranzano; Narghes Calcagno; Nicola Ticozzi; Giovanni Battista Perego; Gianfranco Parati; Erminio Torresani; Antonia Ratti; Vincenzo Silani
Journal:  J Neurol       Date:  2022-07-04       Impact factor: 6.682

5.  Ketamine Mitigates Neurobehavioral Deficits in a Canine Model of Hypothermic Circulatory Arrest.

Authors:  Katherine Giuliano; Eric Etchill; Ana K Velez; Mary Ann Wilson; Mary E Blue; Juan C Troncoso; William A Baumgartner; Jennifer S Lawton
Journal:  Semin Thorac Cardiovasc Surg       Date:  2022-01-05

Review 6.  Tracing Neurological Diseases in the Presymptomatic Phase: Insights From Neurofilament Light Chain.

Authors:  Lorenzo Gaetani; Lucilla Parnetti; Paolo Calabresi; Massimiliano Di Filippo
Journal:  Front Neurosci       Date:  2021-05-24       Impact factor: 4.677

7.  Serum neurofilament light as biomarker of seizure-related neuronal injury in status epilepticus.

Authors:  Giada Giovannini; Roberta Bedin; Diana Ferraro; Anna Elisabetta Vaudano; Jessica Mandrioli; Stefano Meletti
Journal:  Epilepsia       Date:  2021-11-21       Impact factor: 6.740

Review 8.  Recent advances in the diagnosis and prognosis of amyotrophic lateral sclerosis.

Authors:  Stephen A Goutman; Orla Hardiman; Ammar Al-Chalabi; Adriano Chió; Masha G Savelieff; Matthew C Kiernan; Eva L Feldman
Journal:  Lancet Neurol       Date:  2022-03-22       Impact factor: 59.935

9.  Comparative diagnosis interest of NfL and pNfH in CSF and plasma in a context of FTD-ALS spectrum.

Authors:  Isabelle Quadrio; Jean-Michel Dorey; Jean Escal; Anthony Fourier; Maité Formaglio; Luc Zimmer; Emilien Bernard; Hélène Mollion; Muriel Bost; Mathieu Herrmann; Elisabeth Ollagnon-Roman
Journal:  J Neurol       Date:  2021-07-27       Impact factor: 4.849

10.  Synaptopathy Mechanisms in ALS Caused by C9orf72 Repeat Expansion.

Authors:  Agnes L Nishimura; Natalia Arias
Journal:  Front Cell Neurosci       Date:  2021-06-01       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.